Literature DB >> 20072851

Interleukin-32gamma enhances the production of IL-6 and IL-8 in fibroblast-like synoviocytes via Erk1/2 activation.

Yong-Gil Kim1, Chang-Keun Lee, Soo-Hyun Kim, Woo-Shin Cho, Se Hwan Mun, Bin Yoo.   

Abstract

INTRODUCTION: In the present study, we examined the effect of the pro-inflammatory cytokine IL-32gamma, the most biologically active isoform, and its related molecules in fibroblast-like synoviocytes (FLS).
MATERIALS AND METHODS: FLS were isolated from synovial tissues of rheumatoid arthritis (RA) patients. The secretion and expression of IL-6 and IL-8 were examined by ELISA and real-time PCR, and the activation of signaling molecules was evaluated by Western blot, electrophoretic mobility shift assay (EMSA), real-time PCR, and siRNA transfection.
RESULTS: By IL-32gamma stimulation in RA FLS, the expressions of IL-6 and IL-8 were increased significantly, and the phosphorylated Erk1/2 and AP-1 were expressed prominently in Western blot and EMSA. In the Erk1/2 inhibited cells, IL-32gamma stimulation did not increase the mRNA expression of IL-6 and IL-8.
CONCLUSION: Our results suggest that IL-32gamma stimulation can induce the production of IL-6 and IL-8 from RA FLS via Erk1/2 activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072851     DOI: 10.1007/s10875-009-9360-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  Involvement of IL-32 in activation-induced cell death in T cells.

Authors:  Chiho Goda; Taisuke Kanaji; Sachiko Kanaji; Go Tanaka; Kazuhiko Arima; Shigeaki Ohno; Kenji Izuhara
Journal:  Int Immunol       Date:  2006-01-12       Impact factor: 4.823

2.  CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.

Authors:  Rosario García-Vicuña; Maria Victoria Gómez-Gaviro; Maria Jesús Domínguez-Luis; Martina K Pec; Isidoro González-Alvaro; Jose María Alvaro-Gracia; Federico Díaz-González
Journal:  Arthritis Rheum       Date:  2004-12

3.  Interleukin-32: a cytokine and inducer of TNFalpha.

Authors:  Soo-Hyun Kim; Sun-Young Han; Tania Azam; Do-Young Yoon; Charles A Dinarello
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

4.  A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis.

Authors:  H Takayanagi; H Oda; S Yamamoto; H Kawaguchi; S Tanaka; T Nishikawa; Y Koshihara
Journal:  Biochem Biophys Res Commun       Date:  1997-11-17       Impact factor: 3.575

5.  Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts.

Authors:  Atsushi Nishida; Akira Andoh; Makoto Shioya; Shokei Kim-Mitsuyama; Atsushi Takayanagi; Yoshihide Fujiyama
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-31       Impact factor: 4.052

6.  Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction.

Authors:  Kyoung-Woon Kim; Mi-La Cho; Hae-Rim Kim; Ji-Hyeon Ju; Mi-Kyung Park; Hye-Jwa Oh; Joon-Seok Kim; Sung-Hwan Park; Sang-Heon Lee; Ho-Youn Kim
Journal:  Arthritis Rheum       Date:  2007-04

Review 7.  The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.

Authors:  Erika H Noss; Michael B Brenner
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

8.  Identification of the most active interleukin-32 isoform.

Authors:  Ji-Da Choi; Su-Young Bae; Jae-Woo Hong; Tania Azam; Charles A Dinarello; Erk Her; Whan-Soo Choi; Bo-Kyung Kim; Chang-Kwon Lee; Do-Young Yoon; Sun-Jong Kim; Soo-Hyun Kim
Journal:  Immunology       Date:  2008-09-02       Impact factor: 7.397

9.  Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts.

Authors:  Se Hwan Mun; Jie Wan Kim; Seong Su Nah; Na Young Ko; Jun Ho Lee; Ju Dong Kim; Do Kyun Kim; Hyuk Soon Kim; Ji Da Choi; Soo Hyun Kim; Chang Keun Lee; Seung Hwa Park; Bo Kyung Kim; Hyung Sik Kim; Young Mi Kim; Wahn Soo Choi
Journal:  Arthritis Rheum       Date:  2009-03

10.  Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.

Authors:  Hirofumi Shoda; Keishi Fujio; Yumi Yamaguchi; Akiko Okamoto; Tetsuji Sawada; Yuta Kochi; Kazuhiko Yamamoto
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  10 in total

Review 1.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

2.  Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Authors:  Katia Monteleone; Pierluigi Di Maio; Giulia Cacciotti; Francesca Falasca; Maurizio Fraulo; Mario Falciano; Ivano Mezzaroma; Gabriella D'Ettorre; Ombretta Turriziani; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2014-02-20       Impact factor: 3.402

3.  Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha.

Authors:  Masanori Nakayama; Yasuo Niki; Toshiki Kawasaki; Yuki Takeda; Keisuke Horiuchi; Aya Sasaki; Yasunori Okada; Kazuo Umezawa; Hiroyasu Ikegami; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  Arthritis Res Ther       Date:  2012-05-21       Impact factor: 5.156

4.  A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.

Authors:  Katia Varani; Melissa Padovan; Fabrizio Vincenzi; Martina Targa; Francesco Trotta; Marcello Govoni; Pier Andrea Borea
Journal:  Arthritis Res Ther       Date:  2011-12-06       Impact factor: 5.156

5.  IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.

Authors:  Man Sub Kim; Jeong-Woo Kang; Yun Sun Park; Dong Hun Lee; Yesol Bak; Taeho Kwon; Do-Young Yoon
Journal:  Oncotarget       Date:  2015-02-28

6.  Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways.

Authors:  Tiantian Zhu; Liuqiang Zhang; Shuang Ling; Ju Duan; Fei Qian; Yiming Li; Jin-Wen Xu
Journal:  Mediators Inflamm       Date:  2014-10-16       Impact factor: 4.711

7.  Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.

Authors:  Eun-Jin Lee; Sang-Min Kim; Bongkun Choi; Eun-Young Kim; Yeon-Ho Chung; Eun-Ju Lee; Bin Yoo; Chang-Keun Lee; Seokchan Hong; Beom-Jun Kim; Jung-Min Koh; Soo-Hyun Kim; Yong-Gil Kim; Eun-Ju Chang
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

8.  Campylobacter concisus Impairs Sodium Absorption in Colonic Epithelium via ENaC Dysfunction and Claudin-8 Disruption.

Authors:  Praveen Kumar Nattramilarasu; Roland Bücker; Fábia Daniela Lobo de Sá; Anja Fromm; Oliver Nagel; In-Fah Maria Lee; Eduard Butkevych; Soraya Mousavi; Claudia Genger; Sigri Kløve; Markus M Heimesaat; Stefan Bereswill; Michal R Schweiger; Hans Linde Nielsen; Hanno Troeger; Jörg-Dieter Schulzke
Journal:  Int J Mol Sci       Date:  2020-01-07       Impact factor: 5.923

Review 9.  Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis.

Authors:  Verica Paunovic; Margaret M Harnett
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

10.  High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.

Authors:  Eun-Ju Lee; Eun-Jin Lee; Yeon-Ho Chung; Da-Hyun Song; Seokchan Hong; Chang-Keun Lee; Bin Yoo; Tae-Hwan Kim; Ye-Soo Park; Soo-Hyun Kim; Eun-Ju Chang; Yong-Gil Kim
Journal:  Arthritis Res Ther       Date:  2015-12-04       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.